Loading...
01/10 05:51
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance with a 20.3% revenue increase and a 25.1% rise in adjusted EBITDA. The company is actively expanding through acquisitions and has a solid cash position. The guidance remains optimistic with stable EBITDA margins and growth in personal care and home health segments. Despite some uncertainties in the Q&A, like the caregiver app's impact, overall sentiment is positive, supported by strategic acquisitions and potential favorable rate movements in key states. Given the company's small-cap status, these factors suggest a positive stock price reaction.
Total Revenue $349.4 million, an increase of 21.8% compared to $286.9 million for Q2 2024. The growth was driven by consistent organic growth and contributions from the Gentiva Personal Care operations acquisition.
Adjusted Earnings Per Share (EPS) $1.49, an increase of 10.4% compared to $1.35 for Q2 2024. The increase was supported by revenue growth and operational efficiencies.
Adjusted EBITDA $43.9 million, an increase of 24.5% compared to $35.3 million for Q2 2024. This was driven by revenue growth and improved operational performance.
Cash on Hand $91 million as of June 30, 2025. The company reduced bank debt by $30 million during the quarter, leaving a balance of $173 million.
Personal Care Same-Store Revenue Growth 7.4% year-over-year for Q2 2025. This was supported by strong hiring trends and favorable rate support in key markets like Illinois.
Hospice Same-Store Revenue Growth 10% year-over-year for Q2 2025. The growth was driven by higher average daily census and patient days.
Home Health Same-Store Revenue Decreased by 6% year-over-year for Q2 2025. However, profitability improved due to rightsizing of the expense base.
Gross Margin Percentage 32.6%, a slight increase from 32.5% in Q2 2024. The improvement was attributed to meeting certain payroll tax thresholds.
Adjusted G&A Expenses 20% of revenue, a slight decrease from 20.2% in Q2 2024. This reflects operational efficiencies.
Net Cash Flow from Operations $22.5 million for Q2 2025. Consistent cash collections contributed to this performance.
Gentiva Personal Care Operations: The acquisition completed in December 2024 added approximately $280 million in annualized revenues, significantly expanding market coverage.
Helping Hands Home Care Acquisition: Acquired on August 1, 2025, this provider in Western Pennsylvania adds $16.7 million in annualized revenues, expanding personal care density and adding home health and hospice operations.
Illinois Reimbursement Rate Increase: Effective January 1, 2026, a 3.9% increase in the base hourly reimbursement rate to $30.80 per hour is expected to add $17.5 million in annualized revenues.
Texas Reimbursement Rate Increase: Effective September 1, 2025, a 9.9% increase in the base hourly reimbursement rate to $17.13 per hour is expected to add $17.7 million in annualized revenues.
Revenue Growth: Total revenue for Q2 2025 was $349.4 million, a 21.8% increase compared to Q2 2024.
Adjusted EBITDA: Increased by 24.5% to $43.9 million compared to Q2 2024.
Hiring Performance: Achieved 105 hires per business day in Q2 2025, maintaining strong hiring trends.
Acquisition Strategy: Focus on both clinical and non-clinical acquisitions to increase density and geographic coverage in current states.
Advocacy Against Medicare Payment Reductions: Opposing the proposed 6.4% reduction in Medicare payments to home health agencies for 2026, citing potential negative impacts on care availability.
Clinical Hiring Challenges: The company acknowledges that clinical hiring remains challenging and geographically variable, which could impact the ability to meet operational needs in certain areas.
Medicare Payment Reductions: The proposed 6.4% aggregate reduction in Medicare payments to home health agencies in 2026 could significantly impact the availability of home health care services and lead to higher costs for patients requiring facility-based care.
Regulatory Clawback: CMS's proposed clawback of past payments to maintain budget neutrality is viewed as improper and could negatively affect financial stability and service availability.
Home Health Segment Decline: The home health segment experienced a 6% decrease in same-store revenue compared to the previous year, indicating operational and financial challenges in this area.
Dependence on Federal Approval: The implementation of reimbursement rate increases in Illinois and Texas is subject to federal approval, creating uncertainty in realizing projected revenue growth.
Acquisition Risks: While acquisitions are a key growth strategy, there is inherent risk in integrating new operations and achieving expected synergies, particularly with large acquisitions like Gentiva.
Illinois Reimbursement Rate Increase: Effective January 1, 2026, Illinois will implement a 3.9% increase in the base hourly reimbursement rate to $30.80 per hour, expected to add approximately $17.5 million in annualized revenues with margins in the low 20% range.
Texas Reimbursement Rate Increase: Effective September 1, 2025, Texas will implement a 9.9% increase in the base hourly reimbursement rate to $17.13 per hour, expected to add approximately $17.7 million in annualized revenues with margins just over 20%.
Hospice Reimbursement Rate Update: Effective October 1, 2025, CMS will implement a 2.6% increase in hospice reimbursement rates.
Home Health Proposed Payment Rule: CMS proposed a 6.4% aggregate reduction in Medicare payments to home health agencies for 2026, amounting to an estimated $1.1 billion decrease compared to 2025. Addus is advocating for adjustments to this proposal.
Acquisition Strategy: Addus plans to continue pursuing acquisitions that expand geographic coverage and density, focusing on both clinical and non-clinical opportunities. Recent acquisitions include Helping Hands Home Care in Pennsylvania, adding $16.7 million in annualized revenues.
Personal Care Segment Growth: The company expects volume growth to contribute more significantly to same-store revenue growth, targeting a minimum of 2% year-over-year growth in same-store hours.
Capital Allocation and Debt Reduction: Addus will maintain a disciplined capital allocation strategy, focusing on debt reduction and strategic acquisitions, supported by a strong balance sheet and reduced net leverage ratio.
The selected topic was not discussed during the call.
The earnings call summary and Q&A reveal strong financial performance, strategic expansions, and positive hiring trends, particularly in Texas. The company is executing well on acquisitions and capital allocation, with expectations for margin improvement in 2026. Despite some uncertainties, the overall sentiment is positive due to strategic growth initiatives and stable financial health. Given the market cap, the stock is likely to see a moderate positive reaction.
The earnings call highlights strong financial performance with a 20.3% revenue increase and a 25.1% rise in adjusted EBITDA. The company is actively expanding through acquisitions and has a solid cash position. The guidance remains optimistic with stable EBITDA margins and growth in personal care and home health segments. Despite some uncertainties in the Q&A, like the caregiver app's impact, overall sentiment is positive, supported by strategic acquisitions and potential favorable rate movements in key states. Given the company's small-cap status, these factors suggest a positive stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
